Orencia - Abatacept - Dosage - Side Effects - Interactions - Warnings
Orencia (abatacept) drug information, dosage, side effects, drug interactions, and warnings. Orencia, generic drug name abatacept, is the first-in-class selective T-Cell Co-Stimulation Modulator. Orencia (abatacept) is given as an intravenous infusion.
- A - Z: Arthritis Drugs
- A - Z: Biologics / Blockers
- A - Z: Drug Costs
- Needlephobia Overview
- Rheumatoid Arthritis
Orencia - 10 Things You Should Know
Orencia or abatacept is a biologic drug approved for the treatment of moderate to severe rheumatoid arthritis in adults and the treatment of moderate to severe polyarticular juvenile idiopathic arthritis in children 6 years old and older. Orencia is not a TNF blocker, as is Enbrel, Remicade, and Humira. Orencia is a T-cell co-stimulation modulator.
Orencia vs. TNF Antagonists - What's The Difference Between Orencia And Other Biologics?
Orencia (abatacept) is the first approved T-cell co-stimulation modulator approved for the treatment of rheumatoid arthritis. How is Orencia (abatacept) different from Enbrel, Humira, Remicade, and Anakinra?
Orencia (Abatacept) Approved For Rheumatoid Arthritis
Orencia (abatacept) is the first T-cell co-stimulation modulator approved for the treatment of rheumatoid arthritis.
Drugs A-Z - Orencia / Abatacept
Patient education for Orencia / abatacept. Orencia may be used for the treatment of rheumatoid arthritis in adults. Generic abatacept is not yet available.
Are Some Arthritis Patients Unsuitable Candidates For Biologic Drugs?
Orencia is one of the biologic drugs used to treat inflammatory types of arthritis.
Rheumatoid Arthritis - Test Your Knowledge
Rheumatoid arthritis (RA) is triggered by a malfunction in the immune system. The cause of the malfunction is unknown. How much do you know about RA? Take Rheumatoid Arthritis - Test Your Knowledge.
Patient Information: Orencia (Abatacept)
Patient information for Orencia (Abatacept), from Bristol-Myers Squibb Company.
Drugs Approved By The FDA: Orencia (Abatacept)
Orencia (abatacept) is a soluble fusion protein. Orencia (abatacept) is produced through recombinant DNA technology in mammalian cells. Orencia (abatacept) has activity as a selective costimulation modulator with inhibitory activity on T lymphocytes, from CenterWatch.
